{"url_path":"/sec/dyn/8-k/2026-06-17/item-2-03","section_key":"item-2-03","section_title":"Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-17","source_url":"https://www.sec.gov/Archives/edgar/data/1818794/0001818794-26-000003-index.html","accession_number":"0001818794-26-000003","cik":"0001818794","ticker":"DYN","issuer_name":"Dyne Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1818794/0001818794-26-000003-index.html","primary_entity_key":"0001818794","primary_entity_name":"Dyne Therapeutics, Inc."},"word_count":94,"has_tables":true,"body_markdown":"Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.\n\n \n\nThe information set forth in Item 1.01 of this Current Report on Form 8-K is hereby incorporated by reference herein.\n\n \n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nDYNE THERAPEUTICS, INC.\n\n \n\n \n\n \n\nDate: June 17, 2026\n\nBy:\n\n/s/ John G. Cox\n\n \n\n \n\nName:\n\nJohn G. Cox\n\n \n\n \n\nTitle:\n\nPresident and Chief Executive Officer"}